Research ExplorerJournalsLANCET HIV

LANCET HIV - Lancet HIV

Bibliographical data

ISSNs2352-3018

Publications

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
Turkova, A., Waalewijn, H., Chan, M. K., Bollen, P. D. J., Bwakura-Dangarembizi, M. F., Kekitiinwa, A. R., Cotton, M. F., Lugemwa, A., Variava, E., Ahimbisibwe, G. M., Srirompotong, U., Mumbiro, V., Amuge, P., Zuidewind, P., Ali, S. S., Kityo, C. M., Archary, M., Ferrand, R. A., Violari, A., Gibb, D. M., Burger, D., Ford, D., Colbers, A. & ODYSSEY Trial Team, 09.2022, In: LANCET HIV. 9, 9, p. E627-E637

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial
Amuge, P., Lugemwa, A., Wynne, B., Mujuru, H. A., Violari, A., Kityo, C. M., Archary, M., Variava, E., White, E., Turner, R. M., Shakeshaft, C., Ali, S., Nathoo, K. J., Atwine, L., Liberty, A., Bbuye, D., Kaudha, E., Mngqibisa, R., Mosala, M., Mumbiro, V., Nanduudu, A., Ankunda, R., Maseko, L., Kekitiinwa, A. R., Giaquinto, C., Rojo, P., Gibb, D. M., Turkova, A., Ford, D. & ODYSSEY Trial Team, 09.2022, In: LANCET HIV. 9, 9, p. e638-e648

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

View all (2)